AI Assistant
Blog
Pricing
Log In
Sign Up
Unique
SLC12A2-ROS1
fusion is associated with marked response to crizotinib in lung adenocarcinoma
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
